However adequately powered studies with larger sample size and longer follow-up duration, are required to fully dissect the relationship between anti-TNF-α therapy, endothelial dysfunction and actual cardiovascular events, in order to determine the long-term consequences of anti-TNF-α therapy on endothelial function and cardiovascular morbidity and mortality in individuals with RA. Here, TNF is linked to endothelial dysfunction.